{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:59:47Z","timestamp":1781629187938,"version":"3.54.5"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T00:00:00Z","timestamp":1654387200000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2022,5,25]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Idiopathic orbital inflammation (IOI) is a group of orbital inflammatory diseases of unknown etiopathogenesis. We investigated whether patients with IOI have clinical heterogeneity based on the presence (typical group) or absence (atypical group) of a unique onset that periocular inflammatory symptoms emerge suddenly but progress slowly.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This retrospective cohort study included 195 patients diagnosed with IOI. We analysed the clinical data of patients, including the outcomes of corticosteroid treatment, in two subgroups stratified on the basis of the presence (130 patients) or absence (65 patients) of the unique onset.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients in the typical group were significantly younger at disease onset than those in the atypical group (median age; 52 vs 65 years, p=0.002); had more ocular adnexa-specific lesions, namely, dacryoadenitis, myositis, scleritis and optic perineuritis (78% vs 45%, p=0.00001); and had significantly fewer associations with immune-mediated inflammatory diseases (4% vs 15%, p=0.004). Among 30\/119 patients (25%) who were steroid refractory in the typical group, a long period of time from symptom onset to initiation of treatment was a significant steroid-refractory risk factor (OR: 16.7), whereas, among the 18\/40 patients (45%) who were steroid refractory in the atypical group, intraconal diffuse lesions were a significant steroid-refractory risk factor (OR: 8.8).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This cohort study suggests clinical heterogeneity between the two subgroups of patients with IOI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2022-001005","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:30:10Z","timestamp":1654515010000},"page":"e001005","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical heterogeneity between two subgroups of patients with idiopathic orbital inflammation"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-0267","authenticated-orcid":false,"given":"Toshinobu","family":"Kubota","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Nagoya Medical Center, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Iwakoshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagoya Medical Center, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"2025090109382663000_7.1.e001005.1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamaophthalmol.2017.1581","article-title":"Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach","volume":"135","author":"Mombaerts","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2025090109382663000_7.1.e001005.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100885","article-title":"Non-Specific orbital inflammation: current understanding and unmet needs","volume":"81","author":"Lee","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"2025090109382663000_7.1.e001005.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.01.002"},{"key":"2025090109382663000_7.1.e001005.4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s10384-021-00857-1","article-title":"Clinico-epidemiological analysis of 1000 cases of orbital tumors","volume":"65","author":"Goto","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"2025090109382663000_7.1.e001005.5","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.45"},{"key":"2025090109382663000_7.1.e001005.6","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.16"},{"key":"2025090109382663000_7.1.e001005.7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2015.11.032","article-title":"Idiopathic Dacryoadenitis: clinical features, histopathology, and treatment outcomes","volume":"163","author":"Andrew","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2025090109382663000_7.1.e001005.8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.191866"},{"key":"2025090109382663000_7.1.e001005.9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/IOP.0000000000001429","article-title":"Orbital myositis: a comprehensive review and reclassification","volume":"36","author":"McNab","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2025090109382663000_7.1.e001005.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.09.020"},{"key":"2025090109382663000_7.1.e001005.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.11.023"},{"key":"2025090109382663000_7.1.e001005.12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.survophthal.2016.10.007","article-title":"Corticosteroids or biopsy for idiopathic orbital inflammation","volume":"62","author":"Kubota","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"2025090109382663000_7.1.e001005.13","doi-asserted-by":"crossref","unstructured":"Kubota T . Orbital myositis. idiopathic inflammatory myopathies intechopen.com\/chapters\/20192 orbital myositis | IntechOpen 2011.","DOI":"10.5772\/19550"},{"key":"2025090109382663000_7.1.e001005.14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/01676830.2012.681749","article-title":"Evaluation of classification systems for nonspecific idiopathic orbital inflammation","volume":"31","author":"Bijlsma","year":"2012","journal-title":"Orbit"},{"key":"2025090109382663000_7.1.e001005.15","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.12.1711"},{"key":"2025090109382663000_7.1.e001005.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2012.07.024"},{"key":"2025090109382663000_7.1.e001005.17","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313730"},{"key":"2025090109382663000_7.1.e001005.18","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/412896"},{"key":"2025090109382663000_7.1.e001005.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.03.018"},{"key":"2025090109382663000_7.1.e001005.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.01.006"},{"key":"2025090109382663000_7.1.e001005.21","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.082156"},{"key":"2025090109382663000_7.1.e001005.22","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201929"},{"key":"2025090109382663000_7.1.e001005.23","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.138"},{"key":"2025090109382663000_7.1.e001005.24","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-007-0438-1"},{"key":"2025090109382663000_7.1.e001005.25","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s00417-013-2350-3","article-title":"Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature","volume":"251","author":"Kubota","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2025090109382663000_7.1.e001005.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.09.032"},{"key":"2025090109382663000_7.1.e001005.27","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"2025090109382663000_7.1.e001005.28","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306614"},{"key":"2025090109382663000_7.1.e001005.29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.molmed.2020.06.004","article-title":"Ectopic lymphoid organs and immune-mediated diseases: molecular basis for pharmacological approaches","volume":"26","author":"Antonioli","year":"2020","journal-title":"Trends Mol Med"},{"key":"2025090109382663000_7.1.e001005.30","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2006.052688"},{"key":"2025090109382663000_7.1.e001005.31","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2008.067769"},{"key":"2025090109382663000_7.1.e001005.32","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2025090109382663000_7.1.e001005.33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41433-020-0874-4","article-title":"Sarcoid-like granulomatous orbitopathy-presentation, systemic involvement and clinical outcome","volume":"35","author":"Vahdani","year":"2021","journal-title":"Eye"},{"key":"2025090109382663000_7.1.e001005.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00557-7"},{"key":"2025090109382663000_7.1.e001005.35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex261"},{"key":"2025090109382663000_7.1.e001005.36","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00006-5"},{"key":"2025090109382663000_7.1.e001005.37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ophtha.2020.09.012","article-title":"Histopathologic findings in idiopathic orbital myositis","volume":"128","author":"Ben Artsi","year":"2021","journal-title":"Ophthalmology"},{"key":"2025090109382663000_7.1.e001005.38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.10.1187"},{"key":"2025090109382663000_7.1.e001005.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.10.1228"},{"key":"2025090109382663000_7.1.e001005.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.077"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2022-001005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:38:33Z","timestamp":1756744713000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2022-001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,6,6]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjophth-2022-001005"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2022-001005","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}